Heart and Vascular

Cardio Oncology

Heart and Vascular

Cardio Oncology

Cardio-Oncology Program at OhioHealth

Keeping hearts healthy throughout cancer treatment

Using state-of-the-art tools and a collaborative approach to care, our expert cardiologists help cancer patients complete their treatment as safely as possible.

OhioHealth CancerCall

Get in touch with a cancer specialist who can answer your questions and connect you to our cancer physicians, programs and services. Contact OhioHealth CancerCall Monday-Friday, 8 AM-5 PM.

Prevention, early detection and prompt treatment of side effects

At OhioHealth, we know the difference that potentially lifesaving and life-extending cancer treatments can make — but sometimes they cause side effects. Our dedicated team of cardiologists works closely with your oncologists to help prevent, detect and treat possible cardiac side effects related to your cancer treatment. They also have trusted experience in managing pre-existing cardiac conditions and optimizing cardiovascular risks in patients undergoing cancer treatment.


Your care is close to our hearts

Our cardio-oncology clinic locations

For referring offices

When to consider a referral

Before treatment
  • Prior or current use of anthracycline
  • Cardiomyopathy/heart failure prior to treatment
  • Unexplained shortness of breath or chest pain
  • Abnormal echo strain
  • Coronary artery disease
  • Cardiovascular risk factors including
    • Smoking
    • HTN
    • Diabetes
    • Dyslipidemia
    • Obesity based on drug class specific recommendations
  • Abnormal ECG
  • Syncope; QTc > 500ms, and history of arrhythmias
During treatment
  • Changes in ejection fraction
  • Changes in echo strain
  • Heart failure
  • Unexplained shortness of breath or chest pain
  • Pericardial effusion
  • Myocardial ischemia
  • Arrhythmias
  • Syncope
  • Hypotension
  • Uncontrolled hypertension
  • ECG changes
  • QTc > 500mg
After treatment
  • Doxorubicin dose > 240mg/m2, radiation > 30Gy
  • Radiation + Anthracyclines or high dose cyclophosphamide
  • Heart failure symptoms
  • Unexplained shortness of breath or chest pain
  • Cardiovascular risk factor modification